{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:44:44Z","timestamp":1794937484275,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AIRC-CRF Multi-user Equipment Program 2016","award":["19515"],"award-info":[{"award-number":["19515"]}]},{"name":"AIRC-CRF Multi-user Equipment Program 2016","award":["19515"],"award-info":[{"award-number":["19515"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pheochromocytoma (PHEO) and paraganglioma (PGL) are rare neuroendocrine tumors characterized by hemodynamic instability, caused by the paroxysmal release of catecholamines. Patients may develop cardiovascular complications in the perioperative phase due to the massive release of catecholamines, particularly during anesthetic induction and surgical manipulation of the tumor. The aim of this retrospective study was to evaluate the risk factors involved in perioperative hemodynamic instability in patients who underwent surgery for chromaffin tumors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Forty patients (median age 55 [36.50\u201364.50]) undergone surgery for PHEO\/abdominal PGL from January 2011 to December 2016 at the AOU Careggi (Florence, Italy) were retrospectively evaluated. Systolic, diastolic, and mean blood pressure were considered at baseline and during surgery. Patients with blood pressure steadily\u2009&lt;\u2009140\/90\u00a0mmHg before surgery were considered \u201cadequately prepared\u201d. A preoperative therapy with doxazosin, a selective alpha-1 blocker, was started in all patients for at least 14\u00a0days prior to the surgery. The presence of hemodynamic instability was reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Comparing males and females, a significant difference in doxazosin daily dose (<jats:italic>p<\/jats:italic>\u2009=\u20090.018), systolic blood pressure (<jats:italic>p<\/jats:italic>\u2009=\u20090.048), and in the proportion of adequately prepared patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.031) emerged. A positive correlation between preoperative daily dose of doxazosin, tumor size (<jats:italic>B<\/jats:italic>\u2009=\u20090.60, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and urinary normetanephrine levels (<jats:italic>B<\/jats:italic>\u2009=\u20090.64, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) was also observed. Hemodynamic instability occurred in 30.0% of patients. The absence of adequate preparation (<jats:italic>p<\/jats:italic>\u2009=\u20090.012) before surgery, urinary normetanephrine levels (NMNur <jats:italic>p<\/jats:italic>\u2009=\u20090.039), and surgery time (minutes) (<jats:italic>p<\/jats:italic>\u2009=\u20090.021) resulted as risk factors of hemodynamic instability in our series. The use of intraoperative drugs was higher in patients with hemodynamic instability (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). A pre-surgical SBP level of\u2009&gt;\u2009133\u00a0mmHg (OR\u2009=\u20096 CI95% 1.37\u201326.20, <jats:italic>p<\/jats:italic>\u2009=\u20090.017) and an intraoperative SBP and MBP levels of\u2009&gt;\u2009127\u00a0mmHg (OR\u2009=\u200928.80 CI95% 2.23\u2013371.0, <jats:italic>p<\/jats:italic>\u2009=\u20090.010) and\u2009&gt;\u200990\u00a0mmHg (OR\u2009=\u200918.90 CI95% 1.82\u2013196.0, <jats:italic>p<\/jats:italic>\u2009=\u20090.014), respectively, were identified as effective thresholds to recognize patients at higher risk of HI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A preoperative therapy with alpha-blockers is useful, but not sufficient to avoid surgical risks. Patients with higher pre-surgical levels of NMNur, pre-surgical SBP\u2009&gt;\u2009133\u00a0mmHg, and\/or intraoperative SBP\u2009&gt;\u2009127\u00a0mmHg and MBP\u2009&gt;\u200990\u00a0mmHg, should be carefully monitored. A multidisciplinary approach is indispensable to optimize the management of PHEOs\/abdominal PGLs in order to reduce surgical complications.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-023-03072-z","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T09:03:59Z","timestamp":1687856639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hemodynamic parameters in patients undergoing surgery for pheochromocytoma\/paraganglioma: a retrospective study"],"prefix":"10.1186","volume":"21","author":[{"given":"Giuseppina","family":"De Filpo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Sparano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rastrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rapizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Badii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosperi","family":"Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonino","family":"Ercolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Canu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"issue":"6","key":"3072_CR1","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3072_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","volume":"39","author":"H Chen","year":"2010","unstructured":"Chen H, Sippel RS, O\u2019Dorisio MS, Vinik AI, Lloyd RV, Pacak K. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas. 2010;39(6):775\u201383.","journal-title":"Pancreas"},{"issue":"2","key":"3072_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PL Dahia","year":"2014","unstructured":"Dahia PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer. 2014;14(2):108\u201319.","journal-title":"Nat Rev Cancer"},{"issue":"9486","key":"3072_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366(9486):665\u201375.","journal-title":"Lancet"},{"key":"3072_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1196\/annals.1353.044","volume":"1073","author":"M Mannelli","year":"2006","unstructured":"Mannelli M. Management and treatment of pheochromocytomas and paragangliomas. Ann N Y Acad Sci. 2006;1073:405\u201316.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"3072_CR6","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1002\/bjs.11348","volume":"107","author":"S Schimmack","year":"2020","unstructured":"Schimmack S, Kaiser J, Probst P, Kalkum E, Diener MK, Strobel O. Meta-analysis of \u03b1-blockade versus no blockade before adrenalectomy for phaeochromocytoma. Br J Surg. 2020;107(2):e102\u20138.","journal-title":"Br J Surg"},{"issue":"3","key":"3072_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/cen.13284","volume":"86","author":"M Isaacs","year":"2017","unstructured":"Isaacs M, Lee P. Preoperative alpha-blockade in phaeochromocytoma and paraganglioma: is it always necessary? Clin Endocrinol (Oxf). 2017;86(3):309\u201314.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"3072_CR8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00268-005-7839-4","volume":"29","author":"A Agarwal","year":"2005","unstructured":"Agarwal A, Gupta S, Mishra AK, Singh N, Mishra SK. Normotensive pheochromocytoma: institutional experience. World J Surg. 2005;29(9):1185\u20138.","journal-title":"World J Surg"},{"issue":"12","key":"3072_CR9","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1007\/s40618-021-01649-7","volume":"44","author":"M Araujo-Castro","year":"2021","unstructured":"Araujo-Castro M, Pascual-Corrales E, Nattero Chavez L, Mart\u00ednez Lorca A, Alonso-Gordoa T, Molina-Cerrillo J, et al. Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach. J Endocrinol Invest. 2021;44(12):2545\u201355.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"3072_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00464-015-4294-7","volume":"30","author":"L Brunaud","year":"2016","unstructured":"Brunaud L, Nguyen-Thi PL, Mirallie E, Raffaelli M, Vriens M, Theveniaud PE, et al. Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients. Surg Endosc. 2016;30(3):1051\u20139.","journal-title":"Surg Endosc"},{"issue":"16","key":"3072_CR11","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.3390\/cancers14163845","volume":"14","author":"F Bihain","year":"2022","unstructured":"Bihain F, Nomine-Criqui C, Guerci P, Gasman S, Klein M, Brunaud L. Management of patients with treatment of pheochromocytoma: a critical appraisal. Cancers (Basel). 2022;14(16):3845.","journal-title":"Cancers (Basel)."},{"issue":"5","key":"3072_CR12","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/ALN.0000000000003947","volume":"135","author":"B Horvath","year":"2021","unstructured":"Horvath B, Kloesel B, Todd MM, Cole DJ, Prielipp RC. The evolution, current value, and future of the American society of anesthesiologists physical status classification system. Anesthesiology. 2021;135(5):904\u201319.","journal-title":"Anesthesiology"},{"issue":"7","key":"3072_CR13","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1007\/s00464-015-4587-x","volume":"30","author":"S Gaujoux","year":"2016","unstructured":"Gaujoux S, Bonnet S, Lentschener C, Thillois JM, Duboc D, Bertherat J, et al. Preoperative risk factors of hemodynamic instability during laparoscopic adrenalectomy for pheochromocytoma. Surg Endosc. 2016;30(7):2984\u201393.","journal-title":"Surg Endosc"},{"issue":"4","key":"3072_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/bja\/aeh083","volume":"92","author":"P Tauzin-Fin","year":"2004","unstructured":"Tauzin-Fin P, Sesay M, Gosse P, Ballanger P. Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. Br J Anaesth. 2004;92(4):512\u20137.","journal-title":"Br J Anaesth"},{"issue":"9","key":"3072_CR15","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00268-014-2597-9","volume":"38","author":"RY Chang","year":"2014","unstructured":"Chang RY, Lang BH, Wong KP, Lo CY. High pre-operative urinary norepinephrine is an independent determinant of peri-operative hemodynamic instability in unilateral pheochromocytoma\/paraganglioma removal. World J Surg. 2014;38(9):2317\u201323.","journal-title":"World J Surg"},{"issue":"1","key":"3072_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.soc.2015.08.006","volume":"25","author":"CM Kiernan","year":"2016","unstructured":"Kiernan CM, Sol\u00f3rzano CC. Pheochromocytoma and paraganglioma: diagnosis, genetics, and treatment. Surg Oncol Clin N Am. 2016;25(1):119\u201338.","journal-title":"Surg Oncol Clin N Am"},{"issue":"6","key":"3072_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/01.sla.0000164175.26785.06","volume":"241","author":"KW Kercher","year":"2005","unstructured":"Kercher KW, Novitsky YW, Park A, Matthews BD, Litwin DE, Heniford BT. Laparoscopic curative resection of pheochromocytomas. Ann Surg. 2005;241(6):919\u201326 discussion 26-8.","journal-title":"Ann Surg"},{"issue":"4","key":"3072_CR18","first-page":"1480","volume":"86","author":"PF Plouin","year":"2001","unstructured":"Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab. 2001;86(4):1480\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3072_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1213\/00000539-199901000-00004","volume":"88","author":"JL Joris","year":"1999","unstructured":"Joris JL, Hamoir EE, Hartstein GM, Meurisse MR, Hubert BM, Charlier CJ, et al. Hemodynamic changes and catecholamine release during laparoscopic adrenalectomy for pheochromocytoma. Anesth Analg. 1999;88(1):16\u201321.","journal-title":"Anesth Analg"},{"issue":"13","key":"3072_CR20","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1245\/s10434-013-3134-z","volume":"20","author":"S Aliyev","year":"2013","unstructured":"Aliyev S, Karabulut K, Agcaoglu O, Wolf K, Mitchell J, Siperstein A, et al. Robotic versus laparoscopic adrenalectomy for pheochromocytoma. Ann Surg Oncol. 2013;20(13):4190\u20134.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3072_CR21","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1210\/jc.2009-1051","volume":"95","author":"H Bruynzeel","year":"2010","unstructured":"Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CH, Lange JF, et al. Risk factors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endocrinol Metab. 2010;95(2):678\u201385.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3072_CR22","first-page":"1118","volume":"91","author":"MA Kinney","year":"2000","unstructured":"Kinney MA, Warner ME, vanHeerden JA, Horlocker TT, Young WF, Schroeder DR, et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg. 2000;91(5):1118\u201323.","journal-title":"Anesth Analg"},{"issue":"13","key":"3072_CR23","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1245\/s10434-015-4519-y","volume":"22","author":"M Livingstone","year":"2015","unstructured":"Livingstone M, Duttchen K, Thompson J, Sunderani Z, Hawboldt G, Sarah Rose M, et al. Hemodynamic stability during pheochromocytoma resection: lessons learned over the last two decades. Ann Surg Oncol. 2015;22(13):4175\u201380.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3072_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1515\/cclm-2020-0904","volume":"59","author":"G Eisenhofer","year":"2020","unstructured":"Eisenhofer G, Deutschbein T, Constantinescu G, Langton K, Pamporaki C, Calsina B, et al. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma. Clin Chem Lab Med. 2020;59(2):353\u201363.","journal-title":"Clin Chem Lab Med"},{"key":"3072_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijsu.2018.11.018","volume":"61","author":"S Bai","year":"2019","unstructured":"Bai S, Yao Z, Zhu X, Li Z, Jiang Y, Wang R, et al. Comparison of transperitoneal laparoscopic versus open adrenalectomy for large pheochromocytoma: a retrospective propensity score-matched cohort study. Int J Surg. 2019;61:26\u201332.","journal-title":"Int J Surg"},{"issue":"2 Pt 2","key":"3072_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/hy02t2.102820","volume":"39","author":"Y Higashi","year":"2002","unstructured":"Higashi Y, Sasaki S, Nakagawa K, Kimura M, Noma K, Matsuura H, et al. Excess norepinephrine impairs both endothelium-dependent and -independent vasodilation in patients with pheochromocytoma. Hypertension. 2002;39(2 Pt 2):513\u20138.","journal-title":"Hypertension"},{"issue":"1\u20133","key":"3072_CR27","first-page":"173","volume":"28","author":"RJ Head","year":"1991","unstructured":"Head RJ. Hypernoradrenergic innervation and vascular smooth muscle hyperplastic change. Blood Vessels. 1991;28(1\u20133):173\u20138.","journal-title":"Blood Vessels"},{"issue":"11","key":"3072_CR28","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1097\/00004872-200111000-00006","volume":"19","author":"HH Dao","year":"2001","unstructured":"Dao HH, Lemay J, de Champlain J, deBlois D, Moreau P. Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent. J Hypertens. 2001;19(11):1965\u201373.","journal-title":"J Hypertens"},{"issue":"7","key":"3072_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.biopha.2009.09.014","volume":"64","author":"F Galetta","year":"2010","unstructured":"Galetta F, Franzoni F, Bernini G, Poupak F, Carpi A, Cini G, et al. Cardiovascular complications in patients with pheochromocytoma: a mini-review. Biomed Pharmacother. 2010;64(7):505\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"3072_CR30","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1002\/jcsm.13071","volume":"13","author":"Y Pang","year":"2022","unstructured":"Pang Y, Li M, Jiang J, Chen X, Fu Y, Wang C, et al. Impact of body composition and genotype on haemodynamics during surgery for pheochromocytoma and paraganglioma. J Cachexia Sarcopenia Muscle. 2022;13(6):2843\u201353.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"3072_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1530\/EJE-20-1301","volume":"184","author":"K Zawadzka","year":"2021","unstructured":"Zawadzka K, Wi\u0119ckowski K, Ma\u0142czak P, Wysocki M, Major P, P\u0119dziwiatr M, et al. Selective vs non-selective alpha-blockade prior to adrenalectomy for pheochromocytoma: systematic review and meta-analysis. Eur J Endocrinol. 2021;184(6):751\u201360.","journal-title":"Eur J Endocrinol"}],"updated-by":[{"DOI":"10.1186\/s12957-023-03181-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000}}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03072-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-03072-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03072-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T13:40:31Z","timestamp":1700574031000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-03072-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3072"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-03072-z","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12957-023-03181-9","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,27]]},"assertion":[{"value":"18 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12957-023-03181-9","URL":"https:\/\/doi.org\/10.1186\/s12957-023-03181-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of University Hospital of Florence protocol code 59\/11 version 1.3 date 05\/04\/2019. Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}